Moreover, we recommend that future research into gluconeogenesis and liver cancer focus on diabetic murine models of liver cancer, and whether there exists any clinically beneficial information between the relationship of insulin-resistant normal hepatocytes and glucagon-resistant transformed hepatocytes. This evidence concerns the gene INS and liver cancer.